News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625 Results
Type
Article (13)
Company Profile (1)
Press Release (611)
Section
Business (161)
Career Advice (1)
Deals (33)
Drug Development (80)
FDA (12)
Job Trends (12)
News (304)
Policy (35)
Tag
Academia (1)
Allergies (1)
Alliances (46)
Approvals (12)
Best Places to Work (8)
Biotechnology (1)
Cancer (1)
Career advice (1)
Clinical research (81)
COVID-19 (1)
Cystic fibrosis (1)
Data (3)
Earnings (70)
Events (96)
Executive appointments (1)
FDA (12)
Funding (2)
Gene editing (1)
Gene therapy (1)
Healthcare (7)
Immunology and inflammation (1)
Infectious disease (1)
IPO (27)
Job creations (4)
Job search strategy (1)
Layoffs (1)
Legal (4)
Medical device (5)
Medtech (5)
Mergers & acquisitions (12)
Metabolic disorders (1)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (1)
NextGen: Class of 2026 (3)
Obesity (1)
People (39)
Phase 1 (9)
Phase 2 (44)
Phase 3 (30)
Pipeline (4)
Postmarket research (1)
Preclinical (6)
Rare diseases (1)
Real estate (3)
Regulatory (31)
Research institute (1)
Series B (1)
Startups (4)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (21)
2026 (3)
2025 (19)
2024 (14)
2023 (12)
2022 (19)
2021 (14)
2020 (17)
2019 (30)
2018 (28)
2017 (21)
2016 (29)
2015 (32)
2014 (26)
2013 (70)
2012 (83)
2011 (85)
2010 (54)
Location
Asia (9)
Australia (2)
California (17)
Europe (18)
Massachusetts (1)
Minnesota (1)
New York (2)
Northern California (11)
Pennsylvania (1)
Southern California (2)
Texas (4)
United States (25)
625 Results for "evommune inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
Evommune Joins IPO Class With Planned $160M Raise for Immuno Pipeline
With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to come into effect after a certain window has passed.
October 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Evommune Announces Commencement of Initial Public Offering
October 30, 2025
·
3 min read
Press Releases
Evommune Announces Pricing of its Initial Public Offering
November 6, 2025
·
3 min read
Press Releases
Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update
December 12, 2025
·
9 min read
Press Releases
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 10, 2025
·
2 min read
Press Releases
Evommune to Participate in Three Upcoming September 2025 Investor Conferences
August 29, 2025
·
1 min read
Press Releases
Evommune Presents Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria During Late-Breaker at EADV 2025 Congress
September 22, 2025
·
5 min read
Press Releases
Evommune Initiates Phase 2b Trial of its Oral MRGPRX2 Antagonist, EVO756, in Adults with Moderate to Severe Atopic Dermatitis
August 28, 2025
·
5 min read
Press Releases
Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
September 3, 2025
·
2 min read
Press Releases
Evommune Announces Top Line Data from Phase 2 Trial of EVO756 in Chronic Inducible Urticaria Demonstrating Robust Activity and Favorable Safety Profile
May 28, 2025
·
4 min read
1 of 63
Next
